Roel Bogie

Impact of endoscopist training on post-colonoscopy colorectal cancer rate

1

2

3

4

5

6

7

8

9

10 11

Case

Age, gender

79, F 74, F 79, M 80, M 85, F 76, F 76, M 84, F 75, M 80, M 57, F

Indication (index exam)

Sympt

Surv Surv Surv

Sympt

Surv Surv

Sympt Sympt

Surv

Sympt

Time T0-CRC (months)

52

6

56

22

28

51

44

24

15

48

44

Location

Prox

Prox

Dist

Dist

Prox

Prox

Prox

Dist

Dist

Prox

Dist

DD

Comorbidity

DD

DD DD DD DD DD

C-V

DD

C-V

T3 N0M0

T3 N0M1

T2 N0M0

T3 N0M0

T4 N0M0

T3 N0M0

T4 N0M0

T1 N0M0

T1 N0M0

T3 N0M0

Tx N0M1

Tumor Stage

New cancer

Missed lesion

Surveil lance

Missed lesion

Missed lesion

New cancer

Inadeq. exam.

Inadeq. exam.

Surveil lance

Missed lesion

Missed lesion

Likely etiology

Figure 9.4: Clinical characteristics of the patients with a PCCRC from 2008-2012. Sympt = symptoms, Surv = surveillance, Prox = proximal colon, Dist = distal colon, DD = diverticular disease, C-V = cardiovascular disease, Surveillance = nonadherence to surveillance interval, Inadeq exam = inadequate bowel examination.

9

179